BioAge Labs (BIOA) Retained Earnings (2023 - 2026)
BioAge Labs (BIOA) reported Retained Earnings of $73000.0 for Q1 2026, up 100.03% on a YoY basis from $36495.0 in Q1 2025, and down 73.74% sequentially from $278000.0 in Q4 2025.
BioAge Labs (BIOA) Retained Earnings (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Retained Earnings data on file, last reported at $73000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 100.03% year-over-year to $73000.0; the trailing twelve-month figure through Mar 2026 stood at $73000.0 (up 100.03% YoY), and the FY2025 full-year result was $278000.0, down 99.95% from the prior year.
- Retained Earnings declined to $73000.0 in Q1 2026, from $278000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $584.7 million in Q3 2025 to a low of -$287.3 million in Q2 2025.
- A 4-year average of $76.0 million and a median of $136500.0 in 2023 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 536287.16% in 2025, while the deepest fall reached 99.95% in 2025.
- Tracing BIOA's Retained Earnings over 4 years: stood at $164000.0 in 2023, then jumped by 350932.32% to $575.7 million in 2024, then sank by 99.95% to $278000.0 in 2025, then sank by 73.74% to $73000.0 in 2026.
- Business Quant data shows BIOA's Retained Earnings at $73000.0 in Q1 2026, $278000.0 in Q4 2025, and $584.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | 73,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 584.66 Mn |
| Jun 30, 2025 | -287.30 Mn |
| Mar 31, 2025 | -265.74 Mn |
| Dec 31, 2024 | 575.69 Mn |
| Sep 30, 2024 | 109,000.00 |
| Dec 31, 2023 | 164,000.00 |